Michael E. Kuligowski

Author

Also Known As

M E Kuligowski, M Kuligowski, M. E. Kuligowski, M. Kuligowski, M.E. Kuligowski, Michael E. Kuligowski, Michael Kuligowski

Publications

1.1K

Citations

H-Index

Concepts

All Affiliations

Incyte (United States)Probity Medical Research Wroclaw Medical University Icahn School of Medicine at Mount Sinai Oregon Health & Science University

About

Michael E. Kuligowski is an author at Incyte (United States) specializing in medicine, dermatology, and allergy medicine.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	76
2	Allergy	3	3	47
3	Allergy Medicine	3	3	47
4	Health Sciences	1	1	13
5	Anesthesia	1	1	13

Michael E. Kuligowski

Publications

942

Citations

H-Index

Page 1

	Year	Citations
Efficacy and safety of ruxolitinib cream for the treatment of atopic dermatitis: Results from 2 phase 3, randomized, double-blind studies Kim Papp, Jacek C. Szepietowski, Leon Kircik, Journal of the American Academy of Dermatology	2021	274
Treatment of atopic dermatitis with ruxolitinib cream (JAK1/JAK2 inhibitor) or triamcinolone cream Brian Kim, Michael Howell, Kang Sun, Journal of Allergy and Clinical Immunology	2019	215
Effects of ruxolitinib cream on pruritus and quality of life in atopic dermatitis: Results from a phase 2, randomized, dose-ranging, vehicle- and active-controlled study Brian Kim, Kang Sun, Kim Papp, Journal of the American Academy of Dermatology	2020	103
Long-term safety and disease control with ruxolitinib cream in atopic dermatitis: Results from two phase 3 studies Kim Papp, Jacek C. Szepietowski, Leon Kircik, Journal of the American Academy of Dermatology	2022	82
Pharmacokinetics of Ruxolitinib in Patients with Atopic Dermatitis Treated With Ruxolitinib Cream: Data from Phase II and III Studies Xiaohua Gong, Xuejun Chen, Michael E. Kuligowski, American Journal of Clinical Dermatology	2021	65
Improvement in aspects of sleep with etanercept and optional adjunctive topical therapy in patients with moderate‐to‐severe psoriasis: results from the PRISTINE trial Diamant Thaçi, Ricardo Galimberti, Mario Amaya‐Guerra, Journal of the European Academy of Dermatology and Venereology	2013	54
Rapid pruritus reduction with ruxolitinib cream treatment in patients with atopic dermatitis Andrew Blauvelt, Leon Kircik, Kim Papp, Journal of the European Academy of Dermatology and Venereology	2022	22
Safety, pharmacokinetics, and efficacy of ruxolitinib cream in children and adolescents with atopic dermatitis Donald Y.M. Leung, Amy S. Paller, Andrea L. Zaenglein, Annals of Allergy Asthma & Immunology	2022	21
Efficacy and Safety of Ruxolitinib Cream for the Treatment of Atopic Dermatitis: Results From Two Phase 3, Randomized, Double-Blind Studies Kim Papp, Jacek C. Szepietowski, Leon Kircik, SKIN The Journal of Cutaneous Medicine Ruxolitinib CreamAbstract AlgebraAllergyAtopic DermatitisAllergy Medicine	2020	18
Efficacy, Safety, and Long-Term Disease Control of Ruxolitinib Cream Among Adolescents with Atopic Dermatitis: Pooled Results from Two Randomized Phase 3 Studies Lawrence F. Eichenfield, Eric L. Simpson, Kim Papp, American Journal of Clinical Dermatology Ruxolitinib CreamAllergyAtopic DermatitisAllergy MedicinePediatrics	2024	18

Page 1